Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelos Halaris

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Personalized Medicine|August 25, 2023
Utilizing the Systemic Immune-Inflammation Index and Blood-Based Biomarkers in Association with Treatment Responsiveness amongst Patients with Treatment-Resistant Bipolar DepressionKyle Decker, Stephen Murata, Nausheen Baig, et al.
Cellular and Molecular Neurobiology|September 30, 2003
Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cellsMeng-Yang Zhu, John E Piletz, Angelos Halaris, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 25, 2003
Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic menMartin Hasselblatt, Christian Krieg-Hartig, Michael Hüfner, et al.
General Hospital Psychiatry|November 3, 2024
Non-cardiac chest pain: psychopathology, pathophysiology, and response to escitalopramEdwin S Meresh, Anton Shkundin, Erin T Tobin, et al.
Brain, Behavior, & Immunity - Health|May 14, 2023
Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depressionAngelos Halaris, Daniel Hain, Rebecca Law, et al.
Journal of Psychiatric Research|March 20, 2018
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Journal of Psychiatric Research|August 9, 2020
Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Brain, Behavior, and Immunity|January 11, 2020
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depressionStephen Murata, Michael Murphy, Debra Hoppensteadt, et al.
Journal of Personalized Medicine|September 28, 2023
The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction ComorbidityErensu Baysak, Cagan Yildirim, Nurten Sayar, et al.
Frontiers in Public Health|December 23, 2017
Diminution of Heart Rate Variability in Bipolar DepressionBrandon Hage, Briana Britton, David Daniels, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Personalized Medicine|August 25, 2023
Utilizing the Systemic Immune-Inflammation Index and Blood-Based Biomarkers in Association with Treatment Responsiveness amongst Patients with Treatment-Resistant Bipolar DepressionKyle Decker, Stephen Murata, Nausheen Baig, et al.
Cellular and Molecular Neurobiology|September 30, 2003
Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cellsMeng-Yang Zhu, John E Piletz, Angelos Halaris, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 25, 2003
Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic menMartin Hasselblatt, Christian Krieg-Hartig, Michael Hüfner, et al.
General Hospital Psychiatry|November 3, 2024
Non-cardiac chest pain: psychopathology, pathophysiology, and response to escitalopramEdwin S Meresh, Anton Shkundin, Erin T Tobin, et al.
Brain, Behavior, & Immunity - Health|May 14, 2023
Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depressionAngelos Halaris, Daniel Hain, Rebecca Law, et al.
Journal of Psychiatric Research|March 20, 2018
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Journal of Psychiatric Research|August 9, 2020
Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatmentDavid Edberg, Debra Hoppensteadt, Amanda Walborn, et al.
Brain, Behavior, and Immunity|January 11, 2020
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depressionStephen Murata, Michael Murphy, Debra Hoppensteadt, et al.
Journal of Personalized Medicine|September 28, 2023
The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction ComorbidityErensu Baysak, Cagan Yildirim, Nurten Sayar, et al.
Frontiers in Public Health|December 23, 2017
Diminution of Heart Rate Variability in Bipolar DepressionBrandon Hage, Briana Britton, David Daniels, et al.
Pageof 6